DexCom, Inc. DXCM
86.62
(0.85)
(0.97%)
as of 25 Sep
- Market cap
- $33.0B
- P/E
- 33.4×
Follow DXCM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
DexCom, Inc. (DXCM) Free cash flow margin
DexCom, Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 28.3%, up 5.2 percentage points from fiscal 2025 (23.1%). Over the past ten years it has ranged from 0.09% (fiscal 2016) to 111.1% (fiscal 2021); the current reading is higher than 91% of that period. That is above the Medical Devices industry median of −7.24% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 23.1% | 7.47 |
| FY2024 | 15.6% | 1.51 |
| FY2023 | 14.1% | 3.66 |
| FY2022 | 10.5% | (100.60) |
| FY2021 | 111.1% | 96.71 |
| FY2020 | 14.4% | 5.25 |
| FY2019 | 9.11% | 3.67 |
| FY2018 | 5.44% | 1.82 |
| FY2017 | 3.62% | 3.53 |
| FY2016 | 0.09% | (3.82) |
Against its own ten years
Low 0.09%
High 111.1%
Ten-year median
10.5%
Current reading's percentile
91
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| DXCM DexCom, Inc. | 28.3% |
| EW Edwards Lifesciences Corporation compare | 22.0% |
| BSX Boston Scientific Corporation compare | 17.3% |
| STE STERIS plc compare | 15.5% |
| PEN Penumbra, Inc. compare | 14.4% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 12.2% |
| PHG Koninklijke Philips N.V. compare | 8.99% |
| GEHC GE HealthCare Technologies Inc. compare | 7.42% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −7.24% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on DXCM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement